The occurrence of BCR is associated with the metastasis and cancer-specific mortality of PCa, accounting for the poor prognosis of patients; hence, it is essential to develop optimal management approaches for biochemically recurrent PCa patients [5]. The gene discussed is BCR; the disease is posterior cortical atrophy.